BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33623276)

  • 1. Different Clinical Manifestations of Three Prime Repair Exonuclease 1 Mutation: A Case Series.
    Incecik F; Balci S; Kisla Ekinci RM; Herguner OM; Bisgin A; Yilmaz M
    Ann Indian Acad Neurol; 2020; 23(5):699-703. PubMed ID: 33623276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A homozygote TREX1 mutation in two siblings with different phenotypes: Chilblains and cerebral vasculitis.
    Kisla Ekinci RM; Balci S; Bisgin A; Altintas DU; Yilmaz M
    Eur J Med Genet; 2017 Dec; 60(12):690-694. PubMed ID: 28919362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TREX1 double-stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease.
    Lehtinen DA; Harvey S; Mulcahy MJ; Hollis T; Perrino FW
    J Biol Chem; 2008 Nov; 283(46):31649-56. PubMed ID: 18805785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring TREX1 and TREX2 exonuclease activities.
    Hemphill WO; Perrino FW
    Methods Enzymol; 2019; 625():109-133. PubMed ID: 31455522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aicardi-Goutières syndrome protein TREX1 suppresses L1 and maintains genome integrity through exonuclease-independent ORF1p depletion.
    Li P; Du J; Goodier JL; Hou J; Kang J; Kazazian HH; Zhao K; Yu XF
    Nucleic Acids Res; 2017 May; 45(8):4619-4631. PubMed ID: 28334850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New roles for the major human 3'-5' exonuclease TREX1 in human disease.
    Kavanagh D; Spitzer D; Kothari PH; Shaikh A; Liszewski MK; Richards A; Atkinson JP
    Cell Cycle; 2008 Jun; 7(12):1718-25. PubMed ID: 18583934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial chilblain lupus due to a novel mutation in TREX1 associated with Aicardi-Goutie'res syndrome.
    Yi C; Li Q; Xiao J
    Pediatr Rheumatol Online J; 2020 Apr; 18(1):32. PubMed ID: 32293470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TREX1 exonuclease R114H mutation in Aicardi-Goutières syndrome and lupus reveals dimeric structure requirements for DNA degradation activity.
    Orebaugh CD; Fye JM; Harvey S; Hollis T; Perrino FW
    J Biol Chem; 2011 Nov; 286(46):40246-54. PubMed ID: 21937424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defects in DNA degradation revealed in crystal structures of TREX1 exonuclease mutations linked to autoimmune disease.
    Bailey SL; Harvey S; Perrino FW; Hollis T
    DNA Repair (Amst); 2012 Jan; 11(1):65-73. PubMed ID: 22071149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical properties of mammalian TREX1 and its association with DNA replication and inherited inflammatory disease.
    Lindahl T; Barnes DE; Yang YG; Robins P
    Biochem Soc Trans; 2009 Jun; 37(Pt 3):535-8. PubMed ID: 19442247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3' repair exonuclease 1 (TREX1).
    Günther C; Berndt N; Wolf C; Lee-Kirsch MA
    JAMA Dermatol; 2015 Apr; 151(4):426-31. PubMed ID: 25517357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome.
    Rice G; Newman WG; Dean J; Patrick T; Parmar R; Flintoff K; Robins P; Harvey S; Hollis T; O'Hara A; Herrick AL; Bowden AP; Perrino FW; Lindahl T; Barnes DE; Crow YJ
    Am J Hum Genet; 2007 Apr; 80(4):811-5. PubMed ID: 17357087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferonopathies with novel compound heterozygous TREX1 mutations in two siblings with different symptoms responded to tofacitinib.
    Zhang S; Song J; Yang Y; Miao H; Yang L; Liu Y; Zhang X; Liu Y; Wang T
    Pediatr Rheumatol Online J; 2021 Jan; 19(1):1. PubMed ID: 33407657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant mutation of the TREX1 exonuclease gene in lupus and Aicardi-Goutieres syndrome.
    Fye JM; Orebaugh CD; Coffin SR; Hollis T; Perrino FW
    J Biol Chem; 2011 Sep; 286(37):32373-82. PubMed ID: 21808053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Report: Aicardi-Goutières Syndrome Caused by Novel TREX1 Variants.
    Wu D; Fang L; Huang T; Ying S
    Front Pediatr; 2021; 9():634281. PubMed ID: 33996686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human disease phenotypes associated with mutations in TREX1.
    Rice GI; Rodero MP; Crow YJ
    J Clin Immunol; 2015 Apr; 35(3):235-43. PubMed ID: 25731743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease.
    Grieves JL; Fye JM; Harvey S; Grayson JM; Hollis T; Perrino FW
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5117-22. PubMed ID: 25848017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of clinical characteristics of children with Aicardi-Goutieres syndrome in China.
    Wang W; Wang W; He TY; Zou LP; Li WD; Yu ZX; Ma MS; Yang J; Song HM
    World J Pediatr; 2022 Jul; 18(7):490-497. PubMed ID: 35551623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retinal vasculopathy with cerebral leukoencephalopathy carrying TREX1 mutation diagnosed by the intracranial calcification: a case report].
    Komaki R; Ueda T; Tsuji Y; Miyawaki T; Kusuhara S; Hara S; Toda T
    Rinsho Shinkeigaku; 2018 Feb; 58(2):111-117. PubMed ID: 29386495
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.